Contribution of intestinal mucosa to the disease mechanisms of Spondyloarthritis: Unlocking new insights through bioengineered tissue models

What is a severe axial spondyloarthritis?

Interleukin 17-producing C-C motif chemokine receptor 6 (+) conventional CD4(+) T cells are arthritogenic in an animal model of spondyloarthritis

Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop

Reply

STAT1 deficiency underlies a proinflammatory imprint of naive CD4(+) T cells in spondyloarthritis

EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders

Family studies: A useful tool to better understand spondyloarthritis

Clinical image: atypical calcification of dorsal spine

Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestations

Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses

Exploring remission concept in axial spondyloarthritis through the perception of rheumatologists using vignettes and priority ratings

Targeted resequencing of the 13q13 spondyloarthritis-linked locus identifies a rare variant in FREM2 possibly associated with familial spondyloarthritis

Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis" [Joint Bone Spine 2022;89:105344]

Clinical image: bone erosions in a young man

2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis

Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events

Intestinal dysbiosis in spondyloarthritis - chicken or egg?

Monocyte transcriptomes from patients with axial spondyloarthritis reveal dysregulated monocytopoiesis and a distinct inflammatory imprint

COVID-19 chez les patients atteints de rhumatismes inflammatoires chroniques en France : caractéristiques cliniques, facteurs de risque et maintien thérapeutique

Axial spondyloarthritis: emerging drug targets

Rodent Models of Spondyloarthritis Have Decreased White and Bone Marrow Adipose Tissue Depots

COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence

Lessons on SpA pathogenesis from animal models

What Have We Learned From Family-Based Studies About Spondyloarthritis?

Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis

Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci

Epigenetics of spondyloarthritis

Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders

Preface

Granulocyte-macrophage colony-stimulating factor may contribute to spondyloarthritis development in HLA-B27 transgenic rat by affecting conventional dendritic cells function

How to translate genetic findings into clinical applications in spondyloarthritis?

TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis

Both Disease Activity and HLA-B27 Status Are Associated With Gut Microbiome Dysbiosis in Spondyloarthritis Patients

Paradoxical Effects of Endoplasmic Reticulum Aminopeptidase 1 Deficiency on HLA-B27 and Its Role as an Epistatic Modifier in Experimental Spondyloarthritis

Effects of a low-dose IL-2 treatment in HLA-B27 transgenic rat model of spondyloarthritis

HLA-B27 Subtypes Predisposing to Ankylosing Spondylitis Accumulate in an Endoplasmic Reticulum-Derived Compartment Apart From the Peptide-Loading Complex

HLA-B27 alters BMP/TGFβ signalling in Drosophila, revealing putative pathogenic mechanism for spondyloarthritis

Tolerogenic XCR1(+) dendritic cell population is dysregulated in HLA-B27 transgenic rat model of spondyloarthritis

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials

Both Disease Activity and HLA-B27 Status Are Associated With Gut Microbiome Dysbiosis in Spondyloarthritis Patients

The microbiome in spondyloarthritis

Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial

[Anti-TNF alpha-induced eruptive nevi: Three cases]

Prevalence of ultrasound and clinical findings suggestive of inflammatory arthritis in children with skin psoriasis

Abrupt and unexpected stressful life events are followed with increased disease activity in spondyloarthritis: A two years web-based cohort study

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials

Randomized Cross Over Study Assessing the Efficacy of Non-invasive Stimulation of the Vagus Nerve in Patients With Axial Spondyloarthritis Resistant to Biotherapies: The ESNV-SPA Study Protocol

Dual JAK and IL-23 blockade: A mechanistically supported strategy in refractory psoriatic arthritis. A case report

Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial

When generative artificial intelligence answers to Google Trends about spondyloarthritis: what does a French expert panel think about it?

Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial

Prevalence of ultrasound and clinical findings suggestive of inflammatory arthritis in children with skin psoriasis

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials

Correspondence between patient-reported flare and disease activity score variation in axial spondyloarthritis: A 12-months web-based study

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials

Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: meta-analysis of longitudinal studies